Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.


TSXV:COV - Post by User

Bullboard Posts
Post by patmel1on Jun 14, 2013 4:00pm
240 Views
Post# 21528190

AGM and the future of COV

AGM and the future of COV

looks like Brian P. and especially Abe Schwartz were extremely candid in portraying the current lay of the land for COV and more importantly whats in store for the immediate future. I hear that they should be commended and thanked for this honesty.

 

From that, the key focus is on distribution, ie: sales of products that are FDA/health standards approved for sale. The sales teams, the CEO and Abe seem to have turned over many rocks and have much in the pipeline. This is good, but frustrating; many of COVs products are clearly superior products in the the marketplace, but both convincing buyers of this and getting them to commit has been the struggle.

 

At this juncture, any incremental or larger sale (new distributor who will actually sell the stuff, or sign on for some serious $dough like Smith &Nephew did...$5Mil...could you imagine?) will have massive impact on the company. thats where we are at now.

 

And because of this, I am asking any and all who have an interest in the company to step up and help. many shareholders are professionals with a wide network of influencers. Now is the time to call on folks we know in the healthcare space and  introduce the product and or to introduce them to the senior management team at COV and let them run with the ball.

To BE Clear: we are not talking about buying the stock, we are talking about helping find BUYERS of the PRODUCTS that COV produce, the great stuff they make.

 

The boys at COV are pretty bright guys, they (and we) have simply run in to a string of bad luck.

 

Keep in mind that many multi-billion dollar corporations today too experienced their "extremely low point" where tomorrow seemed too far to reach, only to have that one little stroke of luck hit them so late in the day that it completly changed things, turned things around for them. Any little thing now can make all the difference for COV.

 

Yes, I am asking that passive TSXV shareholders step up and get a little active. Anyone can help with distribution and sales. we all know people, step up and help out for all the win.

pm

 

 

 

 

 

 

 

Bullboard Posts